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OBJECTIVE: The relationship between visceral adipose tissue (VAT) and cortisol is a 
controversial area of research interest. The purpose of this study is to explore this relationship 
over a training year in an athletic cohort of female endurance runners. 
METHODS: Female distance runners (juniors, seniors, or red-shirt seniors) from colleges and 
universities  within a 90-minute drive from The Ohio State University and post-collegiate runners 
aged 20-26 years living in Columbus, OH who were actively training for a race (>35 miles per 
week) were eligible for study participation. Laboratory visits occurred three times throughout this 
longitudinal study. Dietary intake and physical activity questionnaires, an iDXA scan, and an 
optional blood draw were completed at each visit. Data was analyzed using SAS software (version 
9.0) Proc Glimmix and SPSS 27 software. Significance was set at an apriori level of p < 0.05.  
RESULTS: Eight participants were included in statistical analysis. The average participant was 
22.5 years old, 162.56 cm tall, weighed 54.58 kg, and had a BMI of 20.70.  No statistically 
significant relationship was observed between VAT and cortisol (p = 0.4779), nor did training 
mileage, dietary fueling, or energy availability reach statistical significance as potential 
covariates.  
CONCLUSION: No statistically significant relationship exists between VAT and serum cortisol 
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Chapter 1: Introduction 
 
Though scientific research has made significant advances in the last twenty years, the 
exact relationship between adipose tissue and chronic disease remains to be elucidated. It has 
long been known that increased levels of adiposity are associated with negative health 
outcomes,1,2 but it is only within the last few decades that body fat has been recognized as a 
metabolically active, hormonally sensitive tissue rather than a benign site for lipid storage. 
Though this has led to many paths of scientific inquiry, one that is gaining attention in scholarly 
literature is the relationship between adipose tissue and stress.3 The human stress response is 
largely involved in homeostatic regulation, and it is known to moderate many body systems 
including metabolism, reproduction, immunity, and cardiovascular function. Hormonally, the 
stress response is regulated by the hypothalamic-pituitary-adrenal (HPA) axis. This regulatory 
pathway begins in the brain, and, after stimulation of the adrenal glands, produces the stress-
related hormone cortisol.  
Of particular interest as of late has been the purported relationship between cortisol and 
visceral adipose tissue (VAT).4 This type of fat, associated with internal organs, is associated 
with greater disease rates than other fat and is increasingly used as an indication of disease risk.5 
Several studies and meta-analyses suggest dysregulation of the HPA axis may be associated with 
visceral obesity,3,6 though it is unknown whether this link is a product of the obese state or rather 
a comorbidity. Therefore, it is obvious that identification of HPA axis dysregulation and cortisol 
secretion in the development of obesity is a complex discussion. Further complicating this 
discussion is the consideration of physical activity as both a catabolic, lipolytic state and a 
stressor that activates the HPA axis,7 as well as the impact dietary intake may have on HPA axis 
regulation. Both physical activity and dietary intake are known to have acute impacts on the 




HPA axis;3,7 however, research is lacking concerning the effects of long-term physical activity 
and dietary intake patterns on HPA axis regulation, cortisol release, and visceral adiposity, 
especially in athletic populations. The present study, conducted with young adult female distance 
runners, seeks to answer the question of (1) whether a relationship exists between changes in 
visceral adiposity and serum cortisol levels over a one-year period of endurance exercise, and (2) 
if training mileage, dietary intake, and/or energy availability impact this relationship. 
Research Question:  
Does a relationship exist between snapshots of visceral adiposity and serum cortisol 
levels over a one-year period of endurance training, and if this relationship may be 




















Chapter 2: Literature Review 
 
The Hypothalamic -Pituitary-Adrenal Axis 
A discussion of human cortisol production begins by considering the activity of the 
hypothalamic-pituitary-adrenal (HPA) axis. This neuroendocrine pathway provides for the stress 
response during prolonged stimuli, which it accomplishes through the production and sequential 
release of three hormones: corticotropin-releasing hormone (CRH) from the hypothalamus, 
adrenocorticotropin hormone (ACTH) from the pituitary, and cortisol from the adrenal glands.3 
Cortisol’s release into the blood stream alters many pathways involved in homeostatic 
regulation, including cognition, reproduction, digestion, and immunity, which together bring 
about the body’s response to stress.8 Generally, this induces a state where energy stores are 
mobilized to maximize cognitive and physical performance, and bodily functions not associated 
with immediate survival experience a temporary cessation.  
The centrality of the HPA axis and its role in homeostatic regulation has made it the 
target of research in both manifest and subclinical disease. Cortisol is considered one of the 
principle stress hormones involved in this pathway, and therefore it is commonly analyzed in 
clinical research as an outcome variable of HPA axis activity. Resting cortisol levels are used to 
indicate basal activity, while cortisol levels following exposure to physiologic or psychologic 
stressors reflect HPA axis activity during the stress response.9 Additionally, though the HPA axis 
is sensitive to regulation by many hormones, cortisol is the hormone most extensively involved 
in negative feedback and regulation of the axis. This feedback occurs at many places in the brain 
and peripheral tissues, but the hypothalamus and hippocampus have been implicated as premier 
feedback sites8 in addition to the pituitary and adrenal glands.  Thus, the measure of cortisol in 




the clinical setting is one approach by which to study HPA axis dysregulation and its 
contribution to adverse metabolic processes. 
When discussing HPA axis dysregulation, it is important to recognize how individual 
genetic differences as well as transient environmental conditions may impact the observed stress 
response. In a 2007 review, Nieuwenhuizen and Rutters suggest that differences in the stress 
reaction may result in part from genetic variation that exists at multiple stages of the HPA 
pathway. They propose ten polymorphisms of the axis, over half of which impact cortisol 
secretion or sensitivity, and the majority of which have been associated with obesity.3 When 
considering testing conditions, Vreeburg et al. conducted a large epidemiological study that 
sought to analyze how study design itself could impact salivary cortisol measures. Their study 
design sought to tightly control the variability of inter-subject testing conditions, but they found 
statistically significant differences in cortisol awakening response (CAR) and diurnal slope 
between subjects who tested on workdays, had differences in time of waking on testing day, and 
the amount of daylight in a given month.9 Interestingly, the amount of daylight impacted more 
cortisol markers than the other study sampling factors, exhibiting a negative correlation with 
total cortisol and a slower decline throughout the day.9 Though further research is needed 
concerning individual variations in HPA axis functioning, sampling factors, and cortisol levels, 
these studies highlight the complex nature of genetic variation and study design variability that 
underline any discussion of metabolic processes. 
 
Cortisol in Humans 
Although cortisol release of the adrenal glands is largely mediated by individual 
physiological and psychological conditions, there are aspects of cortisol production and function 




that are conserved in humans. Healthy individuals exhibit a diurnal cortisol secretory pattern 
marked by elevated morning levels, low evening levels, and variable rates of decrease 
throughout the day.3,5 The internal and external stimuli, real or perceived, that regulate cortisol 
release are thought to do so in an additive manner to the basal levels observed in the diurnal 
slope.5 Following cortisol’s release into vascular circulation, corticosteroid-binding globulin 
(CBG) functions as the chief protein involved in the hormone’s transport (binds approximately 
90% of circulating cortisol), though cortisol also binds albumin with lower affinity.3,10 While 
much of the circulating cortisol is bound, a small fraction is not, and thus is biologically active. 
As well, a small amount of the cortisol precursor, cortisone, is also available for responsive 
conversion to cortisol by the enzyme 11-betahydroxysteroid dehydrogenase type I (11HSD1).10  
In fact, over expression of 11HSD1 has been implicated as a target of cortisol mediated 
inflammation. The body’s regulation of this intricate hormonal web is peripheral as well as 
central.  
At peripheral tissues (such as visceral adipose tissue), cortisol is acted upon by two 
bidirectional 11B-hydroxysteroid dehydrogenases. In vivo, type I (11HSD1) generally uses 
reductase activity to regenerate cortisol from cortisone, while the type II (11HSDII) facilitates 
the reverse dehydrogenase reaction3,10. A study conducted with eight healthy men (defined in 
part as BMI 22.7 ± 0.5 kg/m2, no chronic illnesses reported) found that cortisol concentration 
increased faster in hepatic vein blood (peak reached at 76 min.) than in arterialized blood (peak 
reach at 118 min.) following oral cortisone administration, suggesting that the liver regenerates 
cortisol more rapidly than peripheral tissues.11 However, the same study predicted that 
extrahepatic splanchnic tissues, including visceral adipose tissue, may contribute up to two-thirds 
of total splanchnic cortisol regenerated in non-adrenocorticotropic hormone-dependent 




production (hepatic regeneration rate =15.2 nmol/min, VAT rate = 29.8 nmol/min).11 A study 
analyzing cortisol regeneration in obese subjects showed that women with abdominal body fat 
distribution (android) had a higher urinary cortisone:cortisol ratio, suggesting greater peripheral 
metabolism of cortisol in the kidneys.12 In lay terms, these studies suggest that the majority of 
cortisol regeneration may occur in tissues other than the liver when the HPA axis is in an 
unstressed state.  
 
Cortisol and Visceral Adipose Tissue (VAT) 
Currently, scientific literature supports the involvement of two classes of cellular 
receptors in cortisol metabolism. These are mineralocorticoid receptors (MR) and glucocorticoid 
receptors (GR), both of which act as ligand-activated transcription factors.13 MR receptors are 
generally thought to be bound during basal HPA axis activity, whereas GR receptors are 
implicated in binding activity with high cortisol concentrations that are typically observed 
following adrenal stimulation of the stress response.13 Interestingly, when looking at specific 
tissue responses, VAT has the highest glucocorticoid receptor concentration of any type of fat.4 
This may be significant when considering data that suggests glucocorticoids stimulate adipocyte 
differentiation and maturation,3,10 implying a possible correlation between elevated cortisol 
levels and greater levels of visceral adiposity. Abdominal fat deposition, especially visceral 
adipose tissue, is one of the greatest risk factors of chronic disease,4 so research analyzing the 
relationship between VAT and cortisol may provide insight into the multifactorial etiology of 
obesity and its related diseases.  




A unique relationship between cortisol and visceral adipose tissue is supported by further 
research. Cortisol awakening response (CAR) was measured in lean, obese, and reduced obese 
(defined as recent or current weight loss of greater than 5 kg) subjects to examine the influence 
of body fat distribution on cortisol secretion. No change was found between lean men and lean 
women, but weight distribution and weight loss showed variable effects on cortisol levels in 
obese subjects.14 In looking at 165 overweight, minority youth, cortisol was positively associated 
with visceral adipose tissue but not total body adipose measures such as weight, BMI, total body 
fat, and waist circumference. Additionally, no association was reported between cortisol and 
subcutaneous adipose tissue (SAT), suggesting a specificity in cortisol metabolism that depends 
on the type or location of adipose tissue.4 These studies support the theory that body fat 
distribution, specifically levels of visceral adiposity, are pertinent to a discussion of HPA axis 
dysregulation and individual differences in cortisol secretion. 
Furthermore, the relationship between cortisol and VAT in the development of chronic 
disease may be the product of tissue-specific regulation of cortisol metabolism, as regulated by 
cortisol receptors and 11HSDs. A 2001 study found that men with the highest BMI had a 
statistically significant increase (p< 0.01) in total urinary cortisol metabolites, but this association 
was no longer significant when adjusting for lean body mass. Additionally, the study found no 
difference in total plasma cortisol following a CRH stimulation test.15 Similar results were 
observed in a cohort of 41 Caucasian women: though a positive trend emerged between higher 
ACTH release and greater BMI (P = 0.06), the values remained insignificant.16 These results 
suggest that total cortisol metabolism and/or circulating cortisol levels were not significantly 
elevated in obese subjects. Notably, however, in vitro fat biopsy analysis showed greater 
11HSD1 activity in the adipose tissue of obese subjects,15 which was again reported in the 




adipose tissue of obese women based on correlation analyses of fat biopsies and 
tetrahydrocortisol to tetrahydrocortisone urinary ratios.16 This supports the assertion that the 
type, location, and stimulation frequency of 11HSD enzymes and cortisol receptors may mediate 
cortisol’s effect independent of total cortisol levels.13 The apparent link between visceral adipose 
tissue and peripheral cortisol metabolism suggests that cortisol receptors and hydrogenase 
enzymes may work together to mediate cortisol’s tissue specific responses.  
 
Cortisol, VAT, and Chronic Disease  
In the absence of diagnosed disease known to directly involve the adrenal glands, such as 
Cushing Syndrome and Addison’s Disease, the question regarding cortisol and visceral adipose 
tissue in the development of chronic disease is two-fold: (1) whether there is an association 
between cortisol and chronic disease and (2) if scientific evidence favors a comorbid correlation 
or a causative relationship. When considering the link between cortisol and VAT, obesity 
becomes a germane chronic disease. In the health care setting, some obese patients present with 
many clinical features of hypercortisolism, such as glucose intolerance, dyslipidemia, and a 
central distribution of body fat.3,5,17 Moreover, the phenomena known as thin outside, fat inside 
(TOFI), is used in describing individuals with seemingly normal weight but disproportionate 
amounts of visceral adipose tissue. This suggests that characterizing the relationship between 
cortisol and adipose tissue is important for thin individuals as well as obese who could 
experience adverse health effects and may be at increased risk of developing chronic disease.  
Although the interplay between the HPA axis and diseases of the reproductive system are 
beyond the scope of this particular review, hormones associated with female menstruation must 
be considered when analyzing HPA axis regulation as they have been suggested to impact its 




activity. Interestingly, in a 2009 epidemiological study, Vreeburg et al. found no significant 
impact on cortisol secretion when analyzing the presence of menstruation, phase in the menstrual 
cycle, or oral contraceptive use as potential covariates.9 Additionally, much of the current 
scientific literature involving female subjects is conducted during the follicular phase of the 
menstrual cycle, and the use of oral contraceptives is either an exclusion factor or accounted for 
in statistical analysis. It is likely that menstrual hormones are not a confounding variable in 
studies examining the relationship between HPA axis regulation and cortisol secretion.  
Greater variability in cortisol levels between awakening and before bed have been 
associated with greater sensitivity of the HPA axis to feedback inhibition by dexamethasone,18 
suggesting that regulation of the HPA axis may be more important than total levels of cortisol in 
relation to chronic disease. Dexamethasone, a synthetic glucocorticoid agonist, is used to 
measure sensitivity of the HPA axis to negative feedback by suppressing endogenous cortisol 
and ACTH production.5 When analyzing research using the dexamethasone suppression test, 
retained sensitivity of the pituitary in obesity is both supported and challenged by research. 
Dexamethasone suppression tests including 53 premenopausal, obese women did not show a 
direct effect on cortisol.12 In a study of obese male subjects, total plasma cortisol was actually 
significantly lower (P< 0.01) following dexamethasone suppression and subsequent oral 
cortisone administration.15 These studies suggest that the pituitary may remain sensitive to 
glucocorticoid feedback inhibition with obesity. In contrast, a dexamethasone suppression test 
administered to patients diagnosed with metabolic syndrome showed statistically significant 
higher concentrations of ACTH when compared to controls,17 suggesting patients with metabolic 
syndrome are less sensitive to the negative feedback mechanisms involved in cortisol regulation 
by the HPA axis.  




Alterations of the HPA axis were also seen in 50 premenopausal, obese women kept in a 
tightly controlled environment and subject to standardized timing of meals and activities.6 
Women with abdominal body fat distribution (A-BFD) showed higher salivary cortisol response 
and peak measurement following a dexamethasone suppression test, which may reflect a 
hyperresponsiveness of the HPA axis.6 A-BFD participants also had greater overnight cortisol 
secretion compared to those with peripheral body fat distribution (P-BFD), but no statistical 
difference was reported for 24-hour total cortisol secretion.6 The results of this study suggest that 
the relationship between HPA axis dysregulation and obesity may be evident when considering 
body fat distribution, which would not be surprising considering the proposed relationship 
between cortisol and VAT. The contradictory evidence of these studies does not dismiss the 
involvement of HPA axis dysregulation in obesity, but rather it may showcase variations in fat 
distribution (central/android obesity vs. peripheral/gynoid obesity) that further complicate 
obesity’s multifactorial etiology.  
 
Exercise as a Stress State  
The communication between adipose tissue and HPA cortisol regulation likely has many 
mediators, and exercise should be considered as one such covariate. Not only does physical 
activity (PA) stimulate the HPA axis, therefore making it a stressor,7 but the effects of PA on 
adiposity are well documented. In one example, Wong et al. (2004) found that lower total 
abdominal fat was correlated with higher levels of cardiovascular fitness (reported as VO2 max; 
measured by maximal treadmill testing) at a given BMI in male subjects,19 highlighting the 
correlation between fitness and decreased central adiposity. The catabolic effect of exercise is 
also seen specifically on visceral adiposity. In the same study, men with higher cardiovascular 




fitness had significantly decreased amounts of visceral adipose tissue compared to less fit 
subjects (p < 0.001).19 In fact, this association was seen even though a statistical significance 
between cardiovascular fitness and BMI was not observed. In another study, a cohort of 70-year-
old obese men showed a significant decrease in visceral adipose tissue following a 10-week 
exercise intervention.20 Interestingly, meta-analyses have suggested that, though exercise amount 
and intensity approach a dose-dependent response on VAT decrease, the relationship itself 
remains insignificant.21 It is interesting then to consider how exercise, as a catabolic, cortisol-
releasing state is related to basal cortisol levels, and if the relationship exists in a dose-dependent 
manner.  
Physical activity is known to have acute effects on the HPA axis, but the exact impact 
that PA has on circulating cortisol levels in the short-term is still unknown. In examining PA’s 
immediate impact on cortisol levels, it was found that non-athletic female participants who 
walked 30 minutes prior to engaging in a psychological stress test (Trier Social Stress Test for 
Groups, TSST- G) had lower total salivary cortisol secretion than those in a non-walking 
intervention group.7 This relationship existed independent of prior fitness level,7 suggesting that 
the difference in cortisol secretion was due to study participation in acute exercise rather than 
chronic. However, in another study that measured cortisol immediately following exercise, a 
study population of 53 obese women demonstrated no difference in salivary cortisol levels,12 
though the research team hypothesized the exercise may have mitigated lunch-time cortisol 
response. Therefore, scientific evidence attempting to explain the acute impact of physical 
activity on circulating cortisol levels is contradictory.  
Similarly, scientific literature examining the relationship between habitual exercise and 
chronic cortisol levels is also contradictory. Though much research exists suggesting a 




physiological adaptation to the chronic, repeated stress of exercise, just as many studies exist 
discrediting this hypothesis. Wood et al. reported that females with low heart rates following 30 
minutes of moderate-intensity exercise (defined as ≤ 70% maximal heart rate, 141 bpm ) had 
significantly lower total cortisol secretion compared to those with high heart rates (> 141 bpm),7 
suggesting that prior training and fitness levels may regulate cortisol levels. The participant’s 
average heart rate during walking accounted for approximately nine percent of the observed 
variance in total cortisol secretion (measured as area under the curve with respect to ground 
[AUCg]) in hierarchical multiple regression analysis.7 Likewise, in examining health factors 
thought to modify cortisol secretion, increased physical activity was reported to correlate with 
greater cortisol secretion upon awakening (measured as CAR) followed by a steeper decline in 
cortisol concentrations during the day when compared to individuals who self-reported less PA.9 
The effect of PA on these two cortisol measures had the highest statistical significance of all 
analyzed factors. Individuals who self-reported more PA also showed greater cortisol 
suppression following dexamethasone administration,9 possibly conveying increased sensitivity 
of the HPA axis. In contrast, a study of 44 women, split evenly into higher and lower fitness 
levels by VO2 max parameters, found no statistical significance between plasma cortisol levels 
following the consumption of a mixed meal (61% carb, 20% protein, 19% fat).22 Considering 
that study designs examining the correlation between a snapshot of physical fitness and cortisol 
levels have produced contradictory data, this secondary analysis seeks to examine the statistical 
relationship (or lack thereof) between cortisol levels and variable exercise intensity from 
multiple snapshots taken over a year period. 
When discussing exercise intensity and cortisol, another idea for consideration is 
overtraining, which is typically considered as an inability to fully recover from exercise sessions. 




In a study with six elite weightlifters, no statistical correlation was found between calculated 
fatigue index (mathematical model based on training intensity and training response) and serum 
cortisol levels over a one-year period. Furthermore, the correlation coefficients for each 
individual varied, with half showing a negative correlation and half showing a positive one 
between the two variables.23 In a study at The University of Wisconsin-Madison, 14 female 
varsity swimmers showed no significant increase in baseline salivary cortisol levels taken during 
periods of regular exercise and serum samples taken during a three-week period of overtraining 
(defined as ~ 12,000 yards/day).24 However, in three swimmers identified as having a 
performance decrease between 5-10% of normal capacity, statistically significant increases were 
observed in salivary cortisol compared to teammates who had not experienced performance 
reductions.24 Similarly, in a study of female and male rowers, there was no significant difference 
in subjects’ serum cortisol levels between periods of variable exercise intensity over a seven-
week training period. In subgroup analysis, one male rower who almost collapsed during 
competition had the highest levels of cortisol of all participants four days prior to the event.25 He 
also had the highest serum urea concentration of all study participants, which the researchers 
suggested may indicate greater protein degradation and possible overtraining.25 However, the 
changes in measured serum markers failed to reach significance for this individual. Though no 
association was observed between training intensity and cortisol levels in those athletes with 
sustained capacity for athletic performance, the association between cortisol levels in athletes 
with marked decreases in performance may warrant further scientific investigation. 
 
Cortisol and Dietary Intake 
It is known that acute stress decreases the activity of digestive processes and suppresses 
appetite, while cortisol’s release mobilizes energy stores by inducing the catabolism of glycogen, 




lipid, and protein. Cortisol along with its CRH precursor are proposed to exert this influence on 
dietary intake and macronutrient metabolism by acting on the central biological processes that 
regulate food intake.3 The hypothalamus is sensitive to regulation by hormones associated with 
feeding [leptin and insulin] in addition to cortisol, and the hypothalamus also produces hormones 
that influence dietary intake such as neuropeptide Y and agouti-related peptide.8 However, this 
secondary analysis seeks to examine the reverse question: does there appear to be a correlation 
between serum cortisol levels and a snapshot of dietary intake? Studies addressing this question 
are limited. Due to the HPA axis’s regulatory nature, it is important to approach this discussion 
considering the impact of long-term dietary patterns on cortisol levels. 
When considering the impact that lipid consumption patterns may have on cortisol, many 
studies have chosen to analyze lipid in the subcategories of saturated, monounsaturated, and 
polyunsaturated; a few studies even considered specific fatty acid compounds. In their study of 
adult Mediterranean women, García-Prieto et al. found a statistically significant difference in the 
fatty acid profiles of women with high and medium HPA axis sensitivity (measured by 
dexamethasone suppression test) compared to those with an attenuated response. Total saturated 
fatty acid (SFA) intake was significantly elevated in the low sensitivity group, specifically 
myristic, stearic, and palmitoleic acids when analyzed individually, while monounsaturated fatty 
acid (MUFA) intake was significantly decreased.18 This suggests that lipid intake favoring 
saturated fatty acids rather than unsaturated fatty acids may contribute to decreased sensitivity of 
the HPA axis. In the same study, a statistically significant inverse relationship was also seen 
between dexamethasone suppression and overall fat intake, where greater intake of total fat 
correlated with less HPA axis sensitivity (p = 0.045). In looking at the dietary intake of 165 
overweight Hispanic and African American youth, Gyllenhammer et al. examined omega-3 fatty 




acid intake and found that only youth with omega-3 intake below the study mean showed a 
positive correlation between VAT and plasma cortisol.4 No significance was reported between 
total fat intake and cortisol. Though these studies conflict on whether total fat intake has an 
impact on HPA axis regulation and cortisol secretion, they both suggest that fat intake favoring 
saturated fats rather than unsaturated may have a mediating influence on the relationship 
between HPA axis regulation, cortisol, and visceral adipose tissue. 
Similarly, when considering the long-term intake of carbohydrates, the type of 
carbohydrate consumed may be more important than total carbohydrate consumption. In addition 
to their analysis of omega-3 fatty acid intake as a potential mediator between VAT and cortisol, 
Gyllenhammer et al. observed that high dietary sugar intake (defined as total sugar consumption 
exceeding the study population mean [22.7% of total kcal] and/or ≥ 10% total kcal from added 
sugars) showed a positive correlation between serum cortisol and VAT in regression analysis.4 
However, there was no association observed between VAT and cortisol when considering total 
carbohydrate.4 In another study considering 41 adult women living in Murcia, a town on the 
Mediterranean coast of Spain, the percentage of total kilocalories from carbohydrate was 
positively and significantly correlated with greater suppression of endogenous cortisol 
production, and therefore greater HPA axis sensitivity, following dexamethasone 
administration.18 Though the study did not analyze macronutrient subcategories to differentiate 
between sugar, starch, and fiber, it aids the previous study in suggesting that sugar, but not 
carbohydrate generally, may be a modifying factor in the relationship between cortisol and 
visceral adipose tissue.  
Studies examining the impact of dietary intake on cortisol levels in athletic populations 
are very limited, likely due to training intensity and schedule demand. In one study by Mielgo-




Ayuso et al., the idea that dietary quality rather than total macronutrient intake may modify HPA 
axis regulation is again seen in an athletic population, but the impact of dietary intake on cortisol 
levels is questionable. Twenty-two elite volleyball players from the Spanish First National 
Professional League were recruited to participate in the study during their 29-week competitive 
season, during which every athlete completed the same training program consisting of 
approximately 30 minutes of aerobic exercise, 90 minutes of strength training, and 3 hours of 
game-technique practice daily (match and rest days excluded). A statistically significant inverse 
association was found between carbohydrate intake (measured in g/kg/day) and levels of ACTH 
(r = -0.658).26 Interestingly however, no significant association was found between specific 
macronutrient intake and changes in serum cortisol over the competitive season.26 This supports 
the conclusion found in general populations that greater total carbohydrate intake was associated 
with the regulation and sensitivity of the HPA axis, but no association was reported between 
dietary intake and cortisol levels in athletic populations.  
However, there are quite a few important aspects to note about the previous study that 
highlight the need for more scientific research concerning the relationship between dietary intake 
and cortisol. The study only included general adiposity measures (skinfold measurements) and 
did not consider these measurements as confounding variables in the statistical analysis, which, 
as in the previous study with minority youth, may elucidate the relationship between adiposity, 
cortisol, and HPA axis function. Additionally, the study showed that total carbohydrate intake 
was significantly and continuously lower than the recommended intake for elite athletes in this  
population, an outcome that was again observed in a study considering dietary intake patterns in 
professional female tennis players (measured in both 7-dietary records and 24-hour recall 
performed over a 29-week competitive season).26,27 This may have an additive effect in 




explaining the lack of association observed between adiposity and cortisol in athletic 
populations, as adequate and/or excessive carbohydrate may be a modifying factor between 
cortisol and VAT.4,18 Finally, it should be noted that the study length exceeded half a year, but 
this may not have been sufficient time to observe changes in resting cortisol from diet and/or 
exercise. This suggests that alterations in HPA axis regulation due to diet may require repeat, 
chronic exposure lasting greater than six months to occur to an appreciable extent. The current 
secondary analysis seeks to address these issues by considering body composition, dietary intake, 
and approximately one year of study with three measures over the course of the study. 
 
Closing Summary  
Though this literature review is far from comprehensive, it explored the relationship 
between cortisol and visceral adipose tissue while considering exercise and dietary intake as 
potential mediating factors. A unique relationship was proposed between cortisol and VAT, 
namely that VAT has a higher cortisol receptor concentration than other types of fat,4 and that 
cortisol promotes adipocyte differentiation and maturation.3,10  This relationship may be 
regulated by the activity of 11HDS enzymes and cortisol receptors in a tissue-specific 
manner.15,16 When considering the impact of cortisol and visceral adiposity on chronic disease, it 
was suggested that the relationship between HPA axis dysregulation and obesity may be evident 
when considering body fat distribution, specifically central/android obesity vs. peripheral/gynoid 
obesity.6  When considering how exercise impacts cortisol and VAT, there is greater statistical 
support for an attenuating effect of exercise on VAT than an effect of exercise on cortisol 
levels.19,20 Studies relating basal cortisol levels to habitual exercise are contradictory, and further 
research concerning cortisol and overtraining may help to elucidate this relationship.24 Finally, 




when considering dietary intake, studies tend to point to dietary quality, such as the intake of 
complex carbohydrates and unsaturated fatty acids, as having a potential mediating effect on 





















Chapter 3: Methods 
1. Subjects 
Subjects were recruited for study participation by flyer and word of mouth. Informational 
flyers were sent to head cross-country coaches as well as head athletic trainers of all colleges and 
universities within a 90-minute drive from The Ohio State University. Due to the limited interest 
and/or ability to participate of collegiate female cross-country runners, study participation was 
opened to former collegiate distance runners living in Columbus, OH. Inclusion criteria for 
students included upperclassman status (junior, senior, or red-shirt senior), while inclusion criteria 
for post-collegiate distance runners included actively training for a race, running more than 35 
miles per week during their heaviest training period, and being between 20-26 years of age. 
Subjects were excluded from study if an underclassman or pregnant at the time of laboratory visits 
(health risk associated with radiation of iDXA scans). Eleven women were recruited to partake in 
this longitudinal study, but three were excluded in this secondary analysis due to inadequate serum 
cortisol data. The study was approved by the Institutional Review Board (IRB protocol number 
2018H0248), and participants were required to sign the Consent/HIPAA and iDXA intake forms 
prior to participation.  
 
2. Lab Visit  
Laboratory visits occurred three times throughout this longitudinal study, with the goal of 
pre-season (August), peak-season (November), and post-season (May) visits. Lab visits for 
collegiate runners more closely followed this timeline than did the lab visits for post-collegiate 
runners; lab visits for post-collegiate runners occurred roughly during January, May, and 




October/November/December. During or before each visit, subjects completed a pre-testing 
questionnaire that included dietary intake assessment using the Vioscreen Food Frequency 
Questionnaire (FFQ) and a 3-day (2 weekdays, one weekend day) food record analyzed with 
ESHA food processor (version 11.6.522) as well as estimated physical activity for the previous 
three months using the Modifiable Activity Questionnaire (MAQ). Pace and mileage data were 
collected as standard interview questions during each patient’s iDXA scans. Training volume was 
then calculated by multiplying mileage times the inverse of pace, and energy availability was 
calculated by subtracting calories expended from calories consumed and dividing by the 
individual’s lean body mass (LBM). On the day of their laboratory visit, subjects were asked to 
fast 3-4 hours prior to the morning visit, abstain from alcohol consumption for 12 hours prior, 
avoid vigorous activity for 12 hours prior, and dress in appropriate athletic attire.  
 
2.1 iDXA  
The laboratory protocol included calibration of the iDXA machine prior to its use on each 
day of laboratory visits. Each lab visit included a full set of iDXA scans including the total-body 
scan, thus body composition was provided as a 3-compartment model.  The CoreScan software is 
included on the GE Lunar iDXA (enCORE software version 15 SP4) and estimated the amount of 
visceral adiposity (VAT) for each subject at each visit.   
 
2.2 Lab blood draw and analysis  
For participants who opted to partake in the optional blood draw, approximately 25-35 ml 
of blood was drawn by a trained phlebotomist at each laboratory visit. Samples were refrigerated 




and delivered to the hospital laboratory for analysis of cortisol among other analytes.  Some of the 
serum was aliquoted and samples were stored in -80-degree freezer for later analysis of some of 
the inflammatory markers.  
 
3. Statistical Analysis 
SAS software (version 9.0) was used to develop a mixed general linear regression model 
using Proc Glimmix. Proc Glimmix was chosen as it allows each subject to have her own intercept 
and analyze her unique change in serum cortisol level across time (slope). This is an advanced 
regression method, which allows for the control of variables such as training mileage and 
nutritional markers during analysis. Additionally, the Proc Glimmix model is especially useful as 
it allows for the inclusion of study participants with incomplete data sets (specifically cortisol in 
this study) in statistical analysis. Descriptive data was analyzed using SPSS 27 software and was 
used to characterized participants both at entry and at each visit. Significance was set at an apriori 












Chapter 4: Results 
 
Eight female runners from the study were included in data analysis. At the study’s onset, 
the average participant was 22.5 years old, 162.56 cm tall, weighed 54.58 kg, and had a BMI of 
20.70. The age range of participants was 20 – 25 years, as study participation was open to 
competitive post-graduate runners. Notably, one runner met the criteria for underweight BMI 
classification (BMI < 18.5 kg/m2), while the remaining seven participants fell within the normal 
BMI classification (18.5 kg/m2 to 24.9 kg/m2). Participant’s descriptive data at baseline is included 
in Table 1.  
 
Table 1. Participant Characteristics at Baseline 
Anthropometrics Mean Standard Deviation Minimum Maximum 
Age, y 22.50 ± 1.85 20.00 25.00 
Height, cm 162.56 ± 5.282 152.40 168.90 
Weight, kg 54.68 ± 4.8561 45.60 61.10 
BMI, kg/m2 20.70 ± 1.9131 17.80 24.00 
 
When looking at participant characteristics by visit, average plasma cortisol was lowest 
among participants at visit 2 (15.591 mcg/dL) and peaked at visit 3 (19.729 mcg/dL). Similarly, 
average participant mileage followed the same pattern, with its lowest recorded value of 35.00 
miles/week at visit 2 and rising to 39.67 miles/week at visit 3. Conversely, average VAT mass 
decreased at each visit, starting at 0.209 kg at visit 1 and ending at 0.150 kg on visit 3. Average 
pace increased at each visit, and training volume varied due to individual differences in 




competition preparation. These data are shown in Table 2. It is important to note that these data 
are snapshots of the measured markers and do not represent continuous changes/trends.  
 
Table 2. Participant Characteristics by Visit 
  
Visit 1 Visit 2 Visit 3 
Cortisol, mcg/dL 17.054 (4.563) 15.591 (4.398) 19.729 (8.915) 
VAT, kg 0.209 (0.147) 0.163 (0.095) 0.150 (0.090) 
Total Body Fat, kg 11.02 (2.43) 10.98 (2.79) 11.93 (3.11) 
Mileage, miles/week 38.50 (11.43) 35.00 (16.33) 39.67 (20.66) 
Pace, minutes/mile 7.813 (0.704) 7.833 (0.931) 8.083 (0.665) 
Training Volume, mileage*pace-1 5.022 (1.719) 3.791 (0.957) 4.354 (2.337) 
*Values reported as mean (SD) 
 
Figure 1. Participant Plasma Cortisol by Visit 
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Figure 2. Participant VAT Mass by Visit 
*Lines do not represent gradual change over time and are only included to visualize trends in individual values. 
 
Figure 3. Average Cortisol and VAT by Visit  
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Figure 4. Average Cortisol and Mileage by Visit 
*Lines do not represent gradual change over time and are only included to visualize trends in individual values. 
 
VAT and Cortisol 
 The relationship between VAT and cortisol was nonsignificant in bivariate or higher 
multivariate analyses. Analyzing VAT mass in relation to cortisol alone produced a p-value of 
0.4779 (Table 4), while multivariate analysis controlling for visit produced a larger p-value of 
0.5737 (Table 5). Additionally, visit was analyzed as a potential contributing variable for both 
VAT and cortisol to ensure variance in individual testing dates did not impact the study outcomes. 
No significant relationship was found between visit and either VAT or cortisol. (Table 3). 
Table 3. The Impact of Visit on VAT and Cortisol  
                               The Impact of Visit on VAT and Cortisol  
Dependent Variable Type III Test P-value Visit 1 Visit 2 Visit 3 
VAT 0.3719 0.1897 0.7280 . 







































Average Cortisol and Mileage by Visit
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Training Mileage, Dietary Fueling, and Energy Availability 
When considering potential covariates, no statistically significant relationships were observed 
between VAT, cortisol, and any of the other variables of interest (energy availability, dietary fueling, or 
training mileage). In bivariate analysis, the relationship between VAT and EA produced the lowest p-value 
(p = 0.0710), but this number still failed to reach statistical significance (Table 4). Dietary fueling was 
considered by analyzing caloric and glucose intakes with p-values of p = 0.0939 and p = 0.5271 
respectively. When the same variables were analyzed controlling for visit, the p-values increased (Table 5). 
Training mileage was considered along with pace and training volume to provide a more comprehensive 
view of training status. The relationship between these variables and VAT was analyzed controlling for 
visit and cortisol, and all resulting p-values were greater than p = 0.1500 (Table 6). 
Table 4. VAT Response to Cortisol, EA, Calories, and Glucose 
Impact of Independent Variables on VAT 
Dependent Variable Cortisol EA 
VAT 
Type III Test P-value Estimate Type III Test P-value Estimate 
0.4779 -0.00261 0.0710 0.005004 
Glucose Calories 
Type III Test P-value Estimate Type III Test P-value Estimate 
0.5271 0.001247 0.0939 0.000123 
 
Table 5. VAT Response to Cortisol, EA, Calories, and Glucose when Controlling for Visit 
Impact of Independent Variables on VAT Controlling for Visit 
 
Dependent Variable Type III Test p-Value Visit 1 Visit 2 Visit 3 
 Cortisol  0.5735 Visit 0.4223 0.2591 0.8977 . 
 VAT 
  
EA 0.1500 Visit 0.7740 0.6160 0.9246 . 
Calories 0.2188 Visit 0.8520 0.6231 0.9475 . 
Glucose 0.9794 Visit 0.5859 0.3773 0.8761 . 





Table 6. VAT Response to Mileage, Pace, and Training Volume when Controlling for Visit and Cortisol 
Impact of Independent Variables Controlling for Visit and Cortisol 
Dependent Variable Type III Test p-Value 
 Mileage 0.1522 Visit 0.4608 Cortisol 0.3294 
 VAT Pace 0.6464 Visit 0.6000 Cortisol 0.6008 
  
Training 



















Chapter 5: Discussion 
The primary objective of this study was to determine if a relationship exists between 
snapshots of visceral adiposity and serum cortisol over a one-year period of endurance training. 
The relationship between VAT and cortisol was nonsignificant in linear regression analysis (p ≥ 
0.4779), and remained nonsignificant when controlling for dietary fueling, energy availability, and 
training mileage as potential covariates. 
Existing research detailing the relationship between VAT and cortisol is limited in athletes. 
Published research typically explores the relationship of cortisol to overweight and obesity, which 
has produced inconsistent, diverse results: both increased and decreased responses of the HPA axis 
and cortisol production have been recorded with overweight and obesity.12,14–17 However, general 
measures of adiposity such as weight, BMI, waist circumference, and total body fat are often used 
in this literature, which may not be appropriate considering cortisol’s specificity for VAT4,14 and 
may help explain the lack of consistency. Studies using BMI or total body fat as a proxy measure 
cannot adequately be compared to the present study, and, because cortisol has not been well 
evaluated next to VAT, few studies were available for comparison. Of the studies included in this 
paper’s literature review, no studies with lean or athletic individuals included VAT as a measured 
value.14,16,23–26 Of the two studies that observe the relationship between adiposity and cortisol in 
non-overweight and non-obese subjects, no data was found suggesting a dysregulation of cortisol 
in this population.14,15 Studies concentrating on athletes only considered cortisol’s response to 
either exercise training or dietary intake and did not include markers of body fatness in analysis.23–
26 
In considering VAT specifically, an observational study by Gyllenhammer et al. showed a 
positive association between cortisol and VAT in 165 overweight, minority youth.4 This contrasts 




the results of the present study. However, endurance runners included in the present study had an 
average VAT mass of 0.209 ± 0.147 kg at baseline, whereas youth in the Gyllenhammer et al. 
study had an average VAT mass of 1.563 ± 1.012 kg,4 an average that is 7x greater (Table 7). 
Additionally, the lowest average VAT mass of the present study was recorded at visit 3 (0.147 ± 
0.101), and the greatest individual VAT mass measured was 0.47 kg (visit 1). Although the 
population in Gyllenhammer et al. is nonathletic African American and Hispanic youth and cannot 
be directly compared to the present study, it is tempting to consider that total levels of visceral 
adiposity and body fatness may be important in elucidating the relationship between cortisol and 
visceral adipose tissue. This idea is supported by the minimal VAT mass in the present study’s 
population, as well as previous studies with lean subjects that showed no statistical significance 
between levels of body fatness and cortisol.14,16 However, it must be noted that subgroup analysis 
in Gyllenhammer et al. showed the association of cortisol and VAT only remained significant in 
subjects with high total and added sugar intakes.4 This suggests then that diet must be considered 
as a potential covariate, and maybe even more so in obesity. More research is needed in both 
general and athletic populations to define this relationship.  
Table 7. VAT and Total Body Fat 
 
Metabolically, athletes rely on blood glucose and muscle glycogen to fuel their exercise, 
and carbohydrate ingestion, especially post-exercise, is critical to maintaining energy stores for 
future exercise. This increased carbohydrate use during exercise increases overall carbohydrate 
Mean (SD) Range Mean (SD) Range
Total Body Fat (kg) 35.4 (12.6) 67.8 11.0 (2.4) 7.4
VAT (kg) 1.563 ± 1.012 5.242 0.209 ± 0.147 0.450
Gyllenhammer Present Study
Levels of VAT in Gyllenhammer and the Present Study




needs compared to inactive individuals. Still, Hinderer previously reported that only one of the 
eight subjects included in the present analysis met the recommended carbohydrate intake 
threshold of 8 g/kg/day for peak performance at their activity level, and three of the eight 
subjects met the criteria for inadequate EA (< 30 kcal/kg fat free mass).28 Inadequate 
carbohydrate intake was also seen in professional female tennis players27 and elite volleyball 
players from the Spanish First National Professional League.26  These volleyball players showed 
no statistically significant association between carbohydrate intake and serum cortisol over a 29-
week competitive season.26  Though the results of Gyllenhammer et al. implicate dietary intake 
as a modifying factor between cortisol and VAT, this may not be a confounding variable in 
athletic populations. Instead, this relationship may be impacted by metabolic demands and intake 
patterns (especially in female athletes) that differ from the general population. 
In looking at runners specifically, Jennewine reported that less than half of 100 
premenopausal female runners were consuming adequate carbohydrates for their activity level as 
defined by the International Olympic Committee (6-10 g/kg/d for 1+ hour of endurance exercise), 
and the average study participant had an EA of 32.6 (± 12.61).29 In subgroup analysis, a 
significant increase was reported in mean serum cortisol of runners with adequate carbohydrate 
intake compared to those with inadequate intake, but no relationship was observed when 
considering carbohydrate intake as a continuous variable.29 Considering that adequate and/or 
excessive carbohydrate may be a modifying factor between cortisol and VAT,4,18 chronic 
inadequate carbohydrate intake and more generally low EA may help explain the lack of 
association observed between dietary intake and cortisol in female athletic populations. More 
research is needed concerning the relationship between carbohydrate intake, cortisol, and VAT, 
but the results of this study suggest the relationship is nonsignificant in female athletes.  




Because training mileage (as well as pace and training volume) data was collected at 
three time points across a year period, this study lends itself to discussing the impact of chronic, 
habitual exercise on cortisol and VAT. The results of the present study suggest that training 
mileage does not impact the relationship between VAT and cortisol. Unfortunately, no studies 
were found for comparison that consider these three variables together in analysis. The 
nonsignificant relationship observed between training mileage and cortisol supports the 
conclusions of a study of 44 women where fitness levels (dependent on VO2 max) had no impact 
on serum cortisol, but it should be noted that this study measured cortisol after consumption of a 
mixed meal.22 In the present study, each participant’s training mileage varied due to the subject’s 
individualized competition dates and training plans, but mileage per week averaged 38.50 at visit 
1, fell to 35.00 at visit 2, and peaked at 39.67 for visit 3. The current literature was searched for 
studies regarding the cortisol response in athletes with higher weekly mileage (i.e. ironman 
competitors or ultramarathoners), but studies in this population have analyzed the cortisol 
response during singular day endurance events rather than habitual training. Interestingly, though 
no runners included in the present study were noted as having decreased performance capacity, 
published research may suggest a relationship between cortisol and training status in overtrained 
athletes. No statistical correlation was found between training intensity and cortisol levels when 
looking at total populations of elite powerlifters, female collegiate varsity swimmers, and 
collegiate rowers,23–25 but increased cortisol levels were observed in teammates who experienced 
marked reductions in athletic performance.24,25 Data measured in this study does not allow for 
subgroup analysis for a potential impact of overtraining.  
 
 





Limitations of this study include convenience sampling methods. Because study 
participants were recruited by flyer, the study sample constitutes a convenience sample, meaning 
data may not be reflective of female endurance runners generally. Participants ideally would be 
selected to participate randomly, minimizing selection bias. Additionally, the small sample size 
(n=8) decreases statistical power, so p-values approximate trends rather than significance. This 
limitation may be corrected by increasing the number of individuals willing and able to 
participate. Compounding the impact of the small sample size are the missing values from three 
subjects in data collection, which suggests a large patient burden associated with scheduling and 
attending multiple in-person visits over a year period. Finally, the highly variable timing between 
visits may have impacted data collection, as testing conditions have been shown to impact 
measured values, specifically cortisol.9 Due to individual differences in training plans, subject 
visits did not always represent the intended pre-season and post-season periods of training in 
parallel with each other. For instance, many study participants trained harder between visits 2 
and 3 then they did between visits 1 and 2. This was not the same for all subjects. Future studies 
would benefit from conducting data collection on standardized days.  
Another important limitation occurred with the subjective data collection techniques.  
Self-reported data is subjective by nature and therefore invites the possibility of inaccuracy, 
intentional or not. The results of the study may have been strengthened by collecting dietary 
intake and physical activity information by objective means. Collecting accurate dietary intake 
records for all eight participants would have been largely infeasible, but physical activity 
information may have been reported by using standardized mileage and pace trackers (such as 
digital running watches). Additionally, this would have provided more comprehensive data of 




each runner’s weekly activity and more accurately reported mileage, pace, and intensity than the 
MAQ estimates.  
Finally, cortisol samples were analyzed at Ohio State’s university hospital and the 
research group was not in possession of them during this time. Samples were placed at the 
hospital laboratory drop-off window, and the time elapsed between drop-off and processing is 
unknown. This introduces the possibility that the sample was mishandled, especially during busy 
intervals. Therefore, the research group would need to retain possession of the samples to be 
confident they were handled the correct way. 
 
Future Studies 
Placing the results of this study in the context of published research was difficult due to 
the lack of standardized testing methods used. Many of the studies discussed in the literature 
review used different measures of adiposity as well as different biomarkers to explore the 
relationship between HPA axis function, cortisol levels, and visceral adiposity. Some studies 
analyzed cortisol precursors (namely ACTH) to suggest a dysregulation of the HPA without also 
measuring cortisol. In one study analyzing athlete’s dietary intake over a competitive season, a 
statistically significant relationship was seen with ACTH that was not seen with cortisol.26 This 
is certainly an area of research that would benefit from standardized approaches as well as 
increased research interest. For athletic populations specifically, it may be beneficial to explore 
the relationship between cortisol and VAT in athletes with relatively high amounts of VAT mass, 
such as those who participate in strongman competitions, or team sports where body composition 
is highly variable by position specialization, such as American football. 





The results of this study support the null hypothesis: no statistically significant relationship 
exists between VAT and serum cortisol over the one-year training period in this cohort of female 
endurance runners. Additionally, no relationship was found between cortisol and VAT with dietary 
intake, energy availability, nor training mileage. Athletes, specifically female endurance runners, 
may present a unique population in which to study this question as their VAT levels, dietary intake, 
and training patterns differ from the general population. Specifically, this population tends to have 
minimal VAT mass and inadequate intake relative to their activity level. Nevertheless, this area of 
study is fertile for research in endurance athletes to further delineate the training response to 
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